ÂÜÀòÂÒÂ×

Gabrielle Romain is an accomplished professional in the field of immuno-oncology, currently serving as the R&D Program Director at Pierre Fabre Group since March 2022, leading a significant scientific program. Prior to this role, Gabrielle held positions as a Senior Scientist at Kite Pharma from May 2017 to May 2022, focusing on CAR T cell discoveries and technology enhancements, and as a Scientist at Tizona Therapeutics, Inc., where contributions included antibody development targeting the tumor microenvironment. Gabrielle's career began with a postdoctoral research scientist role at the University of Houston from February 2012 to July 2016, focusing on anticancer immunotherapies and antiviral vaccines. Academic credentials include a PhD in Immunology and Therapeutic Innovation from Paris-Sud University obtained in 2011, complemented by a Life Science Engineer degree from ENSAIA Nancy awarded in 2006.